SCHEMBL725208

SCHEMBL725208

CCOC(=O)C(C)OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
LMNA P02545 2/20 0.52
HSD17B10 Q99714 1/20 0.52
TSHR P16473 3/20 0.46
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
TBXA2R P21731 1/20 0.40
MAPT P10636 2/20 0.39
GALR3 O60755 1/20 0.39
BLM P54132 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6906507 1.00 ALDH1A1 (0.52) ALDH1A1LMNAHSD17B10TSHRCHRM2
SCHEMBL15744779 0.96 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10TSHRCHRM2
SCHEMBL28391087 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL6943196 0.83 ALDH1A1 (0.50) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL1639255 0.82 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL1639253 0.82 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL6943200 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHRSMN1; SMN2
SCHEMBL21983314 0.81 ALDH1A1 (0.55) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL4444613 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHRMAPT
SCHEMBL12150070 0.81 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199526-A1 METHOD FOR SYNTHESIZING COMPOUND IN WHICH ACETOXYLATION REACTION IS APPLIED TO LACTIC ACID DERIVATIVE HYUNDAI MOTOR COMPANY (KR) 2024-06-20 US claimed
CN-115059456-A Degradable radioactive isotope tracer and preparation method thereof 河南省科学院同位素研究所有限责任公司 2022-09-16 CN claimed
CN-110831690-B Film-forming solution and method for producing separation membrane using same 株式会社大赛璐 2022-05-13 CN claimed
US-12620777-B2 Optical member, laser module including said optical member, and laser device DAICEL CORPORATION (JP) 2026-05-05 US disclosed
EP-4700824-A1 LOW-TEMPERATURE-SINTERING BONDING MATERIAL AND BONDED STRUCTURE Daicel Corporation (JP) 2026-02-25 EP disclosed
EP-4681800-A1 CO2 ABSORBENT INFUSED SOLID Sagentia Ltd (GB) 2026-01-21 EP disclosed
US-20250352942-A1 CO2 ABSORBENT INFUSED SOLID SAGENTIA LTD (GB) 2025-11-20 US disclosed
EP-4012726-B1 ADHESIVE CONDUCTIVE PASTE DAICEL CORP (JP) 2025-10-22 EP disclosed
US-20250276331-A1 HYDROCYCLONE CONTACTOR FOR CARBON DIOXIDE REMOVAL SAGENTIA LTD (GB) 2025-09-04 US disclosed
EP-4609939-A1 HYDROCYCLONE CONTACTOR FOR CARBON DIOXIDE REMOVAL Sagentia Ltd (GB) 2025-09-03 EP disclosed
EP-4523625-A1 ELECTRODE DEVICE FOR LIVING BODY Toppan Holdings Inc. (JP) 2025-03-19 EP disclosed
US-6339155-B1 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-01-15 US disclosed
EP-1112268-A1 CONDENSED HETEROCYCLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2001-07-04 EP disclosed
EP-1101761-A2 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-23 EP disclosed
EP-1095935-A1 6-Hydroxy-5,6-dihydrouracils as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-02 EP disclosed
WO-2000015633-A1 CONDENSED HETEROCYLIC COMPOUNDS AND HERBICIDES CONTAINING THEM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-03-23 WO disclosed
CN-1080932-A Depsipeptide derivative and manufacture method thereof and purposes FUJISAWA PHARMACEUTICAL CO (JP) 1994-01-19 CN disclosed
US-4876265-A APPLYING 2-(2,4-DIMETHYLPHENYLIMINO)-3-METHYLTHIAZONINE CIBA-GEIGY CORPORATION (US) 1989-10-24 US disclosed
US-4617273-A BACILLUS CULTIVATION NOVO INDUSTRI A/S (DK) 1986-10-14 US disclosed
EP-0128714-A2 Alpha-acetolactate decarboxylase enzyme and preparation thereof NOVO NORDISK A/S (DK) 1984-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199526-A1 METHOD FOR SYNTHESIZING COMPOUND IN WHICH ACETOXYLATION REACTION IS APPLIED TO LACTIC ACID DERIVATIVE ALDOA, ADSL, LDHA ALDH1A1 160/4885LMNA 640/4885HSD17B10 163/4885
US-12620777-B2 Optical member, laser module including said optical member, and laser device MARK3, OR10J3, ILK ALDH1A1 3032/4885LMNA 2730/4885HSD17B10 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.